Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
First quarter revenues of $2.65 billion, up 12.1% from 2024 First quarter reported diluted earnings per share ("EPS") of $1.94, up 12.8% from 2024; and adjusted diluted EPS of $2.21, up 8.3% from 2024
Quest Diagnostics (DGX) Earnings Expected to Grow: Should You Buy?
11:06am, Tuesday, 15'th Apr 2025
Quest Diagnostics (DGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How Quest Diagnostics is Placed Ahead of Q1 Earnings
10:31am, Tuesday, 15'th Apr 2025
DGX's first-quarter 2025 performance is likely to have been supported by the ongoing utilization of its Advanced Diagnostics and benefits from acquisitions.
DGX Stock Gains Following the Launch of New AD-Detect Blood Test
07:45am, Friday, 11'th Apr 2025
Quest Diagnostics introduces AD-Detect Abeta, a new laboratory blood test, to detect Alzheimer's disease without any PET imaging and cerebral spinal fluid testing.
Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease
07:53am, Wednesday, 09'th Apr 2025
In an oral presentation at the 2025 AAN Annual Meeting, Quest scientists presented data suggesting the test can accurately assess Alzheimer's disease pathology with greater than 90% sensitivity and s
T-Mobile Leads Five Stocks To Watch As Market Correction Intensifies
08:00am, Saturday, 05'th Apr 2025
This weekend's stocks to watch are defensive plays. They boast strong relative strength, but still suffered losses amid the market sell-off.
8 Upcoming Dividend Increases During Volatile Times
01:43pm, Friday, 04'th Apr 2025
8 Upcoming Dividend Increases During Volatile Times
Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening
07:06am, Wednesday, 02'nd Apr 2025
Providers in the United States may now order the FDA-cleared HPV self-collection solution for their patients to use in their offices or other healthcare settings, with goal to reduce barriers to scree
Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025
04:23pm, Tuesday, 01'st Apr 2025
SECAUCUS, N.J. , April 1, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report first quarter 2025 financial resu
Is Quest Diagnostics Stock Worth Holding Onto Right Now?
09:10am, Thursday, 27'th Mar 2025
Strong momentum in Advanced Diagnostics and strategic acquisitions continues to attract investors to DGX.
DGX Stock Set to Benefit From New Google Cloud Partnership
09:21am, Friday, 21'st Mar 2025
Quest Diagnostics teams up with Google Cloud to streamline data and personalize customer experiences using gen AI.
Tap Billion-Dollar AI Opportunity in Oncology: Stocks in the Spotlight
03:16pm, Wednesday, 19'th Mar 2025
Betting on AI-driven precision oncology companies presents a compelling long-term opportunity for investors. Some of the stocks in focus are BTAI, TEM and DGX.
Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day
07:52am, Wednesday, 19'th Mar 2025
Provides long-term outlook beyond 2025: Revenues expected to grow at 4-5% compound annual growth rate (CAGR); adjusted diluted earnings per share (EPS) expected to grow at 7-9% CAGR Reaffirms guidance
Quest Diagnostics to Collaborate with Google Cloud to Streamline Data and Personalize Customer Experiences Using Generative AI
09:00am, Tuesday, 18'th Mar 2025
SUNNYVALE, Calif. and SECAUCUS, N.J.
Quest Diagnostics Stock Jumps 38% in a Year: What's Behind the Surge?
11:15am, Monday, 03'rd Mar 2025
DGX outperforms the industry and the S&P 500 composite's gain in the past year, driven by strong core performance and contributions from acquisitions.
